This is an Open Letter responding to several harsh criticisms of Socialism AI posted by Professor Tony Williams in the ...

Global markets showed resilience in 2025 as multi-asset investors benefited from solid equity gains and cooling inflation. Click here to read our full analysis.

TLX591-CDx (Illuccix® in approved jurisdictions, 68Ga-PSMA-11): Positive data from Phase 3 study in Chinese patients provides the basis for near-term NDA submission in China.

Bruker faced a tough 2024, with aggressive M&A, $600M preferred issuance, rising debt, and execution issues prompting a ...

It may be part and parcel with it being Christmas or the fact that we’re nearing the end of another year.